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Abstract
Background: The prevalence of variant alleles among single nucleotide polymorphisms (SNPs) is not well known for
many minority populations. These population allele frequencies (PAFs) are necessary to guide genetic epidemiology
studies and to understand the population specific contribution of these variants to disease risk. Large differences in
PAF among certain functional groups of genes could also indicate possible selection pressure or founder effects of
interest. The 50K SNP, custom genotyping microarray (CARe) was developed, focusing on about 2,000 candidate
genes and pathways with demonstrated pathophysiologic influence on cardiovascular disease (CVD).
Methods: The CARe microarray was used to genotype 216 unaffected controls in a study of pre-eclampsia among a
Northern Plains, American Indian tribe. The allelic prevalences of 34,240 SNPs suitable for analysis, were
determined and compared with corresponding HapMap prevalences for the Caucasian population. Further analysis
was conducted to compare the frequency of statistically different prevalences among functionally related SNPs, as
determined by the DAVID Bioinformatics Resource.
Results: Of the SNPs with PAFs in both datasets, 9.8%,37.2% and 47.1% showed allele frequencies among the
American Indian population greater than, less than and either greater or less than (respectively) the HapMap
Caucasian population. The 2,547 genes were divided into 53 functional groups using the highest stringency criteria.
While none of these groups reached the Bonferroni corrected p value of 0.00094, there were 7 of these 53 groups
with significantly more or less differing PAFs, each with a probability of less than 0.05 and an overall probability of
0.0046.
Conclusion: In comparison to the HapMap Caucasian population, there are substantial differences in the prevalence
among an American Indian community of SNPs related to CVD. Certain functional groups of genes and related SNPs
show possible evidence of selection pressure or founder effects.
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Introduction
Substantial progress in understanding the genetic
contribution to human variation and disease has been made in
the past few decades; but the practical application of this
knowledge has not met (perhaps exaggerated) expectations
[1]. In particular, the increased relative risk of genetic variants
for adverse medical conditions in specific populations has been
determined through many case/control and population-based
cohorts, using candidate gene and genome-wide association
(GWA) studies. The population attributable risk, however, of
these variants is highly dependent on their allele frequency, in
concert with interacting genetic and environmental covariates
unique to that population. The population prevalence of these
alleles is also critical to the design of further genetic
epidemiology studies and consideration of public health
screening measures. Most of the current data on population
allele frequency (PAF) is derived from relatively small cohorts,
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focused on major, self-reported ethnic groups, such as the
HapMap [2,3] dataset. Larger cohorts have been genotyped for
small numbers of genetic variants, again, primarily among the
major ethnicities [4–6]. A consortium comprised of the Institute
of Translational Medicine and Therapeutics, the Broad Institute
and the Candidate Gene-Association Resource (CARe) led the
development of a 50K SNP, custom genotyping microarray (the
“IBC array”). This array focuses on candidate genes and
pathways with demonstrated influence on inflammatory
pathways, metabolic phenotypes and the pathophysiology of
cardiovascular disease (CVD). The present study utilizes
genotypes from the IBC CARe microarray obtained from the
control arm (N=216) of a pre-eclampsia study among an
American Indian population in the northern plains of the United
States. Population prevalences were determined and
compared with HapMap Caucasian and other PAFs.
Bioinformatics software was then used to parse the SNPs into
functionally related groups and these groups were searched for
functionalities that exhibit significant group differences in PAF.
Methods
Ethics Statement: Approval was obtained from both the
Aberdeen Area Indian Health Service (IHS) and University of
North Dakota Institutional Review Boards and the tribal
government. Individual, written informed consent was obtained
from each participant. The data raw cannot be deposited to a
public repository, in accordance with the requirements of our
Institutional Review Board and in order to protect participant
privacy. However, this data will be made available upon
request to qualified researchers for analyses consistent with
our consents.
The basis for this analysis are genotypes solely from controls
recruited for a Turtle Mountain Community College (TMCC)
study of pre-eclampsia between 8/04 and 7/12 [7]. The
federally funded IHS, through the hospital and clinic located in
Belcourt, North Dakota, is the primary health care provider for
eligible tribal members of the Turtle Mountain Band of
Chippewa. Controls were identified by automated query of an
electronic medical record database (the Resource, Patient,
Management System [RPMS]) at this facility, using a relevant
group of ICD9 codes. Two controls were ascertained by
contact of the first individual to deliver before and after the
index case. If a potential control declined participation, the
woman delivering during the next prior or subsequent day was
contacted; and this was continued until two controls were
recruited. This method of recruiting controls provides a
relatively unbiased, population-based sample.
Template DNA was collected and processed using salivary
samples and the Oragene (DNA Genotek Inc) system.
Genotyping of the anonymized samples was accomplished by
microarray analysis on the IBC (version 1) microarray at The
Children’s Hospital of Philadelphia. SNPs genotyped are listed
at the IBC Array website [8]. Quality control standards were
monitored with the mean call rate above 98% for all SNPs on
the microarray and less than 4% of samples had a SNP call
rate below 95%.
Results of the microarray genotyping will be available to
qualified investigators with assurances that 1) no attempts will
be made to identify individuals, 2) goals of the analysis are
within the scope of the consent and not for anthropologic
research, and 3) the results will not be used for commercial
purposes.
During initial data analysis a correlation was noted between
the PAF of a subset (13.1%) of SNPs and (100 – PAF) of the
comparison population. This was persisted after careful
attention to possible inconsistencies between strand
designation for the IBC microarray and the NCBI standard
reference allele. Strand conversion was suspected as the
cause and elimination of all SNPs consisting of GC and/or AT
pairs corrected this situation.
HapMap (phases II + III) Caucasian (CEU) and Han Chinese,
Denver (CHD) autosomal allele frequencies of the IBC SNPs
were obtained from the HapMap website [9]. Allele frequencies
for the present study were calculated by counting all available
genotypes for a SNP and 95% confidence intervals were
calculated as the mean PAF +/- 1.96* (√((PAF)*(1-PAF)/(total
number of alleles)) to give the upper and lower bounds. For
PAFs at the margins of the distribution (i.e. 0-1% or 99-100%),
the normal approximation to the binomial distribution is not
applicable; as irrational results, such as a lower 95% CI of
100% for a PAF of 100% are obtained. For this reason, the
upper confidence intervals were set at 1% for a mean of 0%
and the lower confidence interval 99% when the mean was
100%. The 1% value was arrived at by observing that typical
estimated PAFs of 99% had lower 95% CIs about 1% less than
the mean.
Allele frequencies from two populations were designated
significantly different if the upper and lower 95% confidence
intervals did not overlap. The median HapMap sample size was
112 individuals or 224 alleles (mean = 186 alleles), whereas
the median sample size was 216, or 432 alleles (mean = 424
alleles) for the TMCC cohort.
To assess the potential impact of non-Indian admixture on
these findings, Multidimensional Scaling (MDS) analysis was
performed using PLINK v 1.07 [10]. At the SNP level, quality
control was performed and SNPs with genotype call rate ≥0.95,
a minor allele frequency ≥0.1, and a p-value from the Hardy-
Weinberg equilibrium test ≥10-6 were kept. A composite score
of the three principal components from this analysis was used
to dichotomize the population into those most closely related to
CEU and those least related to CEU, which is the ethnic group
in closest genetic proximity to this American Indian population.
The proportion of SNPs with statistically significant PAFs was
then determined for these two groups in the same fashion as
described above. See Figure S1 for a graphic representation.
The National Institute of Allergy and Infectious Disease
bioinformatic website, Database for Annotation, Visualization
and Integrated Discovery (DAVID) v 6.7 [11,12], operating
under the “highest” classification stringency, was used to
categorize the functionality of the 34,240 TMCC SNPs into 53
groups. Within these groups, the number of SNPs with
statistically significant differences in PAF was analyzed using
the Excel binomial distribution function and the average
number of SNPs with differing PAFs among those included in
American Indian Allelic Frequencies
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the groups (47.1%). The probability of finding a group with this
number of differing PAFs was evaluated considering the
Bonferroni correction for multiple tests, which gives a nominal p
value of 0.05/53 = 0.000943. The most typical function of those
groups with fewer or more differing PAFs was determined with
assistance from the GeneCards [13] website and search for
common terms in the “aliases and descriptions” notation for
each gene.
Statistical analysis was primarily carried out using SPSS
version 10.1.0 software. Descriptive statistics report mean (+/-
SD) for continuous variables and proportions with 95% CI for
discrete variables. Statistical significance was set at p<0.05.
Results
Demographic characteristics of the 216 females genotyped
include means (SD) of 23.75 (5.47) years, 27.56 (6.72) Kg/m2,
12.24 (2.21) years of age, body mass index (BMI) and
education respectively. The proportion of current smokers was
46.5% (38.4%-54.7%). The HapMap CEU sample is from Utah
residents with Northern and Western European ancestry; and
the HapMap CHD population is from Chinese residents in
metropolitan Denver, Colorado. The proportion of PAFs in
various ranges in this American Indian population is shown in
Figure 1.
A plot of PAFs from the HapMap CEU population vs the
TMCC population is seen in Figure 2. Of the 34,240 SNPs that
could be compared with the HapMap CEU prevalence, allele
frequencies among this American Indian population were
respectively 9.8%, 37.2% and 47.1% significantly greater,
lesser or either. The analogous results for a comparison of
Denver Han Chinese with this cohort shows 65.0%, 24.4% and
89.4% significantly greater, lesser or either. The distribution of
differing PAFs between these three populations, stratified by
range of American Indian PAFs, is given in Figure 3. In the
range of TMCC PAFs between 20 and 80%, there were 18,451
SNPs that could be compared with HapMap CEU and 54.7%
Figure 1.  The proportion of PAFs in ranges for TMCC and HapMap populations.  
doi: 10.1371/journal.pone.0075080.g001
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and 16.4% showed absolute differences of 10% and 20%,
respectively.
To evaluate the possible influence of admixture in this
population, comparisons were made between the two
partitioned halves of the American Indian population (more and
less closely related to Europeans) and the HapMap CEU
population. This analysis resulted in lessening of the proportion
of differing PAFs (partly related to loss of power from reduced
population size), such that 12.4% of those most closely related
to Europeans had statistically different PAFs, compared with
23.9% of those less closely related.
Comparisons between the three other reports of population-
based PAFs among those of European ethnicity and this
American Indian cohort are shown in Table 1. Of the 92 PAFs
that could be compared between these populations and the
TMCC cohort, a total of 71 (77.1%) were significantly different;
and even 4 of the 7 SNPs (57%) that allowed pair-wise
comparisons among 3 European cohorts themselves showed a
significant difference (Table 1).
Using the “highest” stringency criteria, there were 705 DAVID
identified genes associated with 8,921 SNPs among the 53
functional groups detected. Table 2 shows these 53 groups,
the number of SNPs assigned to each ranged from 2 to 972
with a mean of 168. The number of differing PAFs in each
group and the binomial probability of that number (or more
extreme values) are shown in Table 2. While none of the
groups reach a Bonferroni corrected p value of 0.00094, in total
there were 7 of these 53 groups with either more or less than
expected numbers of differing PAFs. With a nominal p value of
0.05, one would expect fewer than 5 out of 53, and the finding
of 7 has an overall probability of 0.0046. There were 28 of the
53 groups with more differing PAFs, compared with 25 groups
with less. Assuming an equal distribution of “more” and “less”
groups, this is an unremarkable distribution (p=0.392).
The genes identified in the 7 groups with more or less than
expected numbers of differing PAFs are listed in Table 3.
Those groups with decreased numbers of differing PAFs
included the genes for the collagen structural proteins, and
Figure 2.  Plot of TMCC vs HapMap CEU PAFs.  
doi: 10.1371/journal.pone.0075080.g002
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genes coding for transmembrane proteins and the Kell blood
group. Groups with increased numbers of differing PAFs
included one with influence on glucose metabolism; one
involved with immune function, and a group related to drug and
metabolic detoxification pathways.
Discussion
Population-based allelic prevalences are critical data for the
integration and implementation of novel genetic findings into
clinical and public health efforts, as well as furthering future
genetic epidemiology investigations. The present report
provides the most extensive data on PAFs within an American
Indian population, both in terms of the very large number of
SNPs genotyped (over 34,000) and the relatively large number
of individuals genotyped (216). The value of this resource is
enhanced by the fact that the basis of the identified ethnicity
relies on official, legally maintained records dating back
multiple generations, rather than self-reported ethnicity, as in
most other studies.
For reasons that are unclear, there appears to be an
increased number of monomorphic SNPs in the HapMap
populations, as seen in Figure 1. The fact that over twice as
many alleles were genotyped for the TMCC population creates
an increased power to detect low allele frequencies and hence
a decreased likelihood of monomorphic SNPs. It seems
unlikely however, that this would produce the large difference
between populations in proportion of SNPs that are
monomorphic.
These data show a considerable degree of variation between
majority and minority populations in overall SNP prevalence,
even when comparing that portion of the American Indian
population most closely related to Europeans. This is
consistent with reports of differing (by arbitrary absolute values)
PAFs of 22% [4] and 33% [5] between African American and
Caucasian groups, and a somewhat smaller proportion (7.8%)
comparing Caucasian and Mexican Americans. Garte et al. [14]
Figure 3.  The number of SNPs in each TMCC prevalence range with a statistically significant different PAF than HapMap
CEU or CHD MAFs.  
doi: 10.1371/journal.pone.0075080.g003
American Indian Allelic Frequencies
PLOS ONE | www.plosone.org 5 September 2013 | Volume 8 | Issue 9 | e75080
have reported a similar degree of differing PAFs among two
metabolic gene SNPs in Japan versus Korea and Singapore.
An extensive genome-wide association study [15] of body
mass index (BMI) among 1,120 Pima Indian participants,
ascertained largely through familial relationships, used an over
900,000 SNP microarray but found a high rate (35%) of PAFs <
5%. In addition, one SNP with strong genome-wide association
in the European population [16] and a PAF of 21% was
monomorphic in this Pima population. This clearly illustrates
the powerful effect of variant allele frequencies on both study
design and population attributable risk.
Even in a very large Caucasian cohort with self-reported
ancestral region of origin, there were still 19 of 51 SNPs (37%)
with statistically differing PAFs [6]. The current analysis of three
populations of self-identified Caucasian Europeans, showed a
surprisingly high proportion (4/7, 57.1%) of pair-wise
comparisons with differing PAFs.
It must be recognized, however, that the demonstration of
statistically significant differences between populations using
Table 1. Comparisons between TMCC and European PAFs
reported in the literature.
NHANES [4] vs TMCC









Total SNPs 1 3 1 10 14 9 0 38
Differing 0 1 1 7 12 7 0 28
% of Total 0.0 33.0 100.0 70.0 85.7 77.7 0.0 73.7
Cross et al. [6] (European) vs TMCC
Total SNPs 0 1 4 11 8 3 0 27
Differing 0 1 2 9 6 3 0 21
% of Total 0.0 100.0 50.0 81.8 75.0 100.0 0.0 77.7
Cross et al. [6] (American Indian) vs TMCC
Total SNPs 0 1 4 11 8 3 0 27
Differing 0 1 4 7 5 2 0 19
% of Total 0.0 100.0 100.0 63.6 62.5 66.6 0.0 70.3
Huang et al. [5] vs TMCC
Total SNPs 0 2 3 5 13 4 0 27
Differing 0 2 2 5 9 4 0 22
% of Total 0.0 100.0 66.6 100.0 69.2 100.0 0.0 81.5
Huang et al vs Cross vs NHANES*
Total SNPs 0 0 0 4 2 1 0 7
Differing 0 0 0 1 2 1 0 4
% of Total 0.0 0.0 0.0 25.0 100.0 100.0 0.0 57.1
*. Note this last comparison is for any one of the 3 literature reports that differs
from one of the others
large sample sizes and very precise estimates does not
translate into clinically (or public health related) important
differences in PAF. Still, absolute differences in PAF of 10%
and 20% between CEU and this American Indian cohort were
found in 54.7% and 16.4% of SNPs, respectively. This provides
cautionary information for those who may place undue
confidence in the similarity of standard “ethnicities”, especially
those which are self-reported.
When considering SNPs from functionally related genes, we
see that 7 groups showed excessive or reduced numbers of
differing PAFs and that this distribution of groups with a p value
less than 0.05 is highly unusual (p=0.0046). The presence of
fewer differing PAFs could be due to selection pressure since
two of the three groups coded for collagen, which may well be
under selection constraints. The groups with more differing
PAFs could be explained by genes with minimal selection
pressure or a founder effect.
The functionality of those groups with fewer differing PAFs
seemed more related to basic physiologic mechanisms, such
as the structural collagen genes and certain of the
transmembrane proteins, possibly involved in signaling. This
naturally suggests that these critical functions may be more
affected by selection pressure at the species level, and require
more uniformity and representation of these SNPs. Those with
more differing PAFs involved immune response, detoxification
metabolism and glucose metabolism. The latter is of particular
interest given the increased prevalence of diabetes in many
American Indian populations [17].
This study would clearly be strengthened if a greater number
of genotypes were available for both the American Indian and
HapMap PAFs, but the countervailing strength of both these
sources is the very large number of SNPs available for analysis
(tens of thousands) in contrast to the only other analyses with
thousands of genotypes on tens of SNPs. The other strength of
the present report is the use of objective, carefully maintained,
records of ethnic origin, rather than self-reported ethnicity. The
only other report of population-based American Indian PAFs
genotyped only 51 SNPs among 167 individuals of self-
reported ethnicity [6].
In conclusion, these results from a very large number of
SNPs genotyped in a substantial number of American Indian
participants, ascertained in a population-based manner show
that a high proportion of SNP population allele frequencies
differ from those reported in Caucasians from the HapMap
dataset. There also appear to be groups of genes with certain
functionalities which have significantly more or less differing
PAFs. These results will be useful in the design of future
genetic epidemiology studies and may eventually find utility in
public health or clinical screening efforts.
American Indian Allelic Frequencies
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Table 2. Functional groups with significantly increased numbers of PAFs differing from HapMap CEU.
GROUP TOTAL SNPs DIFFERING DAVID GENES PROBABILITY* DIRECTION**
2 70 38 12 0.0928 MORE
5 130 67 15 0.1353 MORE
6 100 49 12 0.3149 MORE
7 144 49 7 0.0010 LESS
8 834 378 93 0.1604 LESS
9 76 31 6 0.1618 LESS
10 84 45 9 0.0973 MORE
11 16 9 7 0.3140 MORE
12 40 17 5 0.3368 LESS
14 367 159 31 0.0810 LESS
15 65 27 6 0.2199 LESS
17 62 34 5 0.0889 MORE
18 49 25 6 0.2439 MORE
19 145 65 12 0.3215 LESS
20 94 40 7 0.2181 LESS
21 105 38 5 0.0156 LESS
22 50 24 9 0.3931 MORE
23 91 36 6 0.0904 LESS
24 72 40 5 0.0600 MORE
25 107 48 13 0.3574 LESS
26 50 20 8 0.1941 LESS
27 84 43 12 0.1947 MORE
28 18 14 5 0.0018 MORE
29 343 147 15 0.0640 LESS
30 551 254 18 0.3344 MORE
31 75 32 5 0.2573 MORE
32 551 266 27 0.2756 MORE
33 628 301 62 0.3238 MORE
34 334 172 25 0.0481 MORE
35 143 82 10 0.0056 MORE
36 31 20 6 0.0166 MORE
37 25 10 11 0.3062 LESS
39 93 46 13 0.2873 MORE
40 423 184 10 0.0754 LESS
41 60 30 5 0.2808 MORE
42 71 37 6 0.1672 MORE
44 32 17 8 0.1949 MORE
46 83 34 9 0.1562 LESS
47 104 40 23 0.0472 LESS
49 16 8 6 0.3140 LESS
50 37 21 6 0.0899 MORE
52 99 42 32 0.2031 LESS
53 41 14 5 0.0651 LESS
Limited to those 43 with probability less than 0.35 of 53 groups in total.
*. Probability of this number (or more extreme comparisons) of SNP PAFs “Differing” out of the total, given an “a priori” probability of 0.471 for a “Differing” SNP PAF.
**. MORE indicates an excess of PAFs differing between the populations and LESS means there was a relative deficit of PAFs differing between the populations.
American Indian Allelic Frequencies
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Table 3. Characteristics of 7 Gene Groups showing significantly more or less SNPs with differing prevalences.
 
Group 7 (collagen), p=0.0010 LESS
COL6A2 COL4A5 COL9A2 COL4A2 COL4A1 COL4A6
Group 28 (insulin regulation, IGF1R), p=0.0018 MORE
EIF2B1 EIF2B3 EIF2B4 EIF2B5 EIF2B2  
Group 35 (immune response, T-cell signaling), p=0.0056 MORE
NFATC4 REL TFAP2B NFATC3 NFATC1 SOX5
NFAT5 NFATC2 FOXJ2 NFE2L2   
Group 21 (collagen), p=0.0156, LESS
COL3A1 COL1A2 COL1A1 COL5A2 COL5A1  
Group 36 (dual specificity phosphatase, Erk/JNK pathway), p=0.0166, MORE
DUSP9 DUSP7 DUSP10 DUSP5 DUSP6 DUSP2
Group 47 (transmembrane proteins, Kell blood group), p=0.0472, LESS
TSPAN31 TMEM61 TMEM132E TMEM63A CD53 PRRT1
ARMC10 SMCR7 TMEM132D MS4A6A PDZK1IP1 C10orf72
MUSTN1 STARD3NL ARV1 C12orf23 C14orf101 C14orf118
HAS3 EVC XKR6 KIAA2013 CCDC109B  
Group 34 (cytochrome P450, drug metabolism), p=0.0481, MORE
CYP4A11 CYP27A1 CYP2D6 CYP2E1 CYP2C9 TBXAS1
CYP3A4 CYP8B1 CYP7A1 CYP2J2 CYP4F2 CYP1A2
CYP2C19 CYP26A1 CYP7B1 CYP17A1 CYP2A6 CYP4B1
CYP3A5 CYP19A1 CYP1B1 CYP2A7 CYP2C18 CYP2C8
American Indian Allelic Frequencies
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Supporting Information
Figure S1.  Plot of Principal Components 1 vs 2, showing
dichotomized TMCC population and selected comparison
populations.  (TIF)
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